Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2001
10/04/2001WO2001073114A2 Reagents and methods for detecting a reduced cofactor
10/04/2001WO2001073113A2 Monooxygenase assays
10/04/2001WO2001073112A1 Method for identifying uv-filter compounds
10/04/2001WO2001073111A2 Cell-free reconstitution of autophagocytosis
10/04/2001WO2001073109A2 Continuous process for manufacture of disposable electro-chemical sensor
10/04/2001WO2001073108A2 A bacterial two-hybrid system for protein interaction screening
10/04/2001WO2001073105A1 Mammalian two-hybrid system
10/04/2001WO2001073091A2 Methods of selection and development of plants having improved root quality and root lodging resistance
10/04/2001WO2001073086A2 Method for genetically modifying a plant
10/04/2001WO2001073050A2 3714, 16742, 23546, and 13887 novel protein kinase molecules and uses therefor
10/04/2001WO2001073035A1 A METHOD FOR SCREENING FOR AUTOIMMUNE DISEASE BY IDENTIFYING POLYMORPHISMS IN IL-12 p40
10/04/2001WO2001073034A2 Beta-like glycoprotein hormone polypeptide and heterodimer
10/04/2001WO2001073032A2 Compositions and methods for the therapy and diagnosis of prostate cancer
10/04/2001WO2001073029A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001073028A2 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor
10/04/2001WO2001073020A1 Materials and methods relating to a novel splice variant of a na+ dependent glutamate transporter
10/04/2001WO2001073015A1 Identification of human gaba transporter
10/04/2001WO2001073014A1 Human survivin interacting protein 1 (sip-1)
10/04/2001WO2001073002A2 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides
10/04/2001WO2001072997A1 MUTANT HUMAN TGF-ss1 GENES
10/04/2001WO2001072995A2 Methods of producing a library and methods of selecting polynucletides
10/04/2001WO2001072994A2 Human urothelial cell specific uroplakin transcriptional regulatory sequences, vectors comprising the same, and methods of use thereof
10/04/2001WO2001072984A1 Plant anthocyanidin rutinoside aromatic acyl transferases
10/04/2001WO2001072978A2 Aryl propenal double bond reductase
10/04/2001WO2001072977A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/04/2001WO2001072966A2 Haplotypes of the pltp gene
10/04/2001WO2001072965A2 Haplotypes of the fkbp8 gene
10/04/2001WO2001072964A2 Detection of viable agents
10/04/2001WO2001072962A2 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
10/04/2001WO2001072926A1 Trityl-type compounds and their use
10/04/2001WO2001072841A2 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001072840A2 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001072839A2 Human g-protein coupled receptors
10/04/2001WO2001072838A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof
10/04/2001WO2001072837A2 Methods of modulating drug clearance mechanisms by altering sxr activity
10/04/2001WO2001072836A2 G-protein coupled receptors
10/04/2001WO2001072834A1 Selectable marker genes
10/04/2001WO2001072830A2 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction
10/04/2001WO2001072822A2 Genes involved in intestinal inflammatory diseases and use thereof
10/04/2001WO2001072781A2 Human genes and expression products
10/04/2001WO2001072780A2 Polynucleotides for diagnosing mammary gland cancer
10/04/2001WO2001072777A2 Human transcription factors
10/04/2001WO2001072773A2 Genes isolated from dendritic cells, gene products and methods employing the same
10/04/2001WO2001072772A2 Calcium binding regulatory subunit
10/04/2001WO2001072766A1 Quality control reagents for nucleic acid microarrays
10/04/2001WO2001072764A1 N?8- and c8¿-linked purine bases and structurally related heterocycles as universal nucleosides used for oligonucleotide hybridization
10/04/2001WO2001072761A2 Haplotypes of the pltp gene
10/04/2001WO2001072328A2 Methods of treating diseases with activated protein c
10/04/2001WO2001072295A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/04/2001WO2001072293A2 Antiprogestins with partial agonist activity
10/04/2001WO2001072132A1 Non-human transgenic animals expressing platelet-derived growth factor c (pdgf-c) and uses thereof
10/04/2001WO2001072123A1 Methods for increasing a cytotoxic t lymphocyte response in vivo
10/04/2001WO2001040274A3 Inhibition of hrsv membrane fusion
10/04/2001WO2001036657A3 Altered type ix collagen gene sequences associated with intervertebral disc disease
10/04/2001WO2001036638A8 Polypeptides and nucleic acids encoding same
10/04/2001WO2001036602A3 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same
10/04/2001WO2001032685A3 Gene expression directed by a super-psa promoter
10/04/2001WO2001021784A3 Pcna-associated cell cycle proteins, compositions and methods of use
10/04/2001WO2001021644A3 Wheat dp proteins and uses thereof
10/04/2001WO2001020017A3 Metal cluster containing nucleotides and nucleic acids, and intermediates therefor
10/04/2001WO2001016375A3 High speed parallel molecular nucleic acid sequencing
10/04/2001WO2001016369A3 Uv excitable fluorescent energy transfer dyes
10/04/2001WO2001016319A3 Compositions and methods for the treatment of immune related diseases
10/04/2001WO2001012778A3 Flocculation of cell material
10/04/2001WO2001011047A3 Dna sequences isolated from human colonic epithelial cells
10/04/2001WO2001004361A3 Detection of hiv-1 by nucleic acid amplification
10/04/2001WO2001000663A3 Catalytically active recombinant memapsin and methods of use thereof
10/04/2001WO2000071564A8 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
10/04/2001WO2000062795A9 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS
10/04/2001WO2000044935A3 Multiplex real-time pcr
10/04/2001WO2000043515A3 Methods of monitoring hiv drug resistance
10/04/2001WO2000039279A9 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/04/2001WO2000017655A9 Water-soluble fluorescent semiconductor nanocrystals
10/04/2001WO2000017327A9 Terpene synthases
10/04/2001WO2000015178A9 Computer implemented pharmacokinetics method and program
10/04/2001WO2000007018A3 Three-hybrid screening method for ligand-protein interactions
10/04/2001WO1999046387A9 Biosynthetic genes for spinosyn insecticide production
10/04/2001US20010027567 DNA molecule encoding recombinatorial substrate and reporter gene; activation by recombinase to effect gain or loss of gene function; transgenic mammal with said DNA; identification of transgene by phenotype of reporter gene
10/04/2001US20010027566 Transgenic animal model of basal cell carcinoma
10/04/2001US20010027251 Mimic or modulate activity of wild-type nucleic acids thereby affecting protein production or activity
10/04/2001US20010027187 Such as hydroxyethylated bis(trimethoxysilylpropyl)amine as well as modified polyamines for use as silylating agents in surface treatment of silica and in formation of nucleic acid arrays
10/04/2001US20010027184 Serine/threonine protein kinase (H-SGK2)
10/04/2001US20010026936 Apparatus for automatic measuring of water toxicity
10/04/2001US20010026935 First and second column select transistors, the column select transistors being adapted for control by column selector, first and second row select transistors, being adapted for control by row selector, output connected to node
10/04/2001US20010026930 Isolating mutant yeast cells with an increased life span by exposing sample of yeast cells from budding yeast strain, for which the life span is known, to a mutagen, plating, replica-plating, culturing
10/04/2001US20010026929 Microfluidic in-line labeling method for continuous-flow protease inhibition analysis
10/04/2001US20010026921 Solid matrix with a intercalator capable of binding DNA, RNA, or DNA-RNA hybrid, a intercalator fluorophore acting as energy acceptor or donator, and a oligo- or polynucleotide probe with a lanthanide metal chelate bound to it
10/04/2001US20010026920 Subsets of particles comprising different known amounts of ligand binding partner sepcific for analytes of interest; providing information relating to high-dose hook effects, dilutional linearity, interfering assay factors, etc.
10/04/2001US20010026919 Contacting tagged target nucleic acids generated from tagged gene specific primers with an array of tag complements under hybridization conditions, and detecting hybridized tag target nucleic acid-tag complements
10/04/2001US20010026918 Reducing background signals; accuracy
10/04/2001US20010026917 DNA detection device
10/04/2001US20010026916 Contacting brain tissue with a fluorescent dye capable of intercalating selectively into nucleic acids, and detecting any fluorescence indicative of senile plaques, neurofibrillary tangles and neuropil threads
10/04/2001US20010026915 Spectral changes in biopolymer
10/04/2001US20010026794 Two heterologous DNA encoding gene products; prolonged half-life
10/04/2001US20010026778 Systems and methods for the active electronic control of biological reactions
10/04/2001EP1144629A3 Further pro polypeptides and sequences thereof
10/04/2001EP1139267A2 Single point interaction screen to predict IC50
10/04/2001EP1139100A2 Reactive probe chip, composite substrate and method for fabrication of the same
10/04/2001EP1138786A2 Specific and universal amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
10/04/2001EP1138785A2 Nucleic acid fragment primer or probe, and method of detecting polyhydroxyalkanoate synthesizing microorganism by using the same